Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03257267
Title Study of REGN2810 in Adults With Cervical Cancer
Recruitment Completed
Gender female
Phase Phase III
Variant Requirements No
Sponsors Regeneron Pharmaceuticals
Age Groups: adult | senior
Covered Countries USA | ITA | GBR | ESP | CAN | BEL | AUS

No variant requirements are available.